Attaya Suvannasankha, MD

Department of Medicine, Indiana University, Indianapolis, IN, USA

Poster(s):

• ((SLA-025)) (SLA-025) Second Primary Malignancy in Patients with Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anti-Cancer Therapy: A Real-World Evidence from a Large US National Claims Database
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• ((C-214)) (C-214) Second Primary Malignancy in Patients with Multiple Myeloma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anticancer Therapy: A Comparative Study Using a Real-World Database
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET